that we got after we published our american story. i think we had — there are factions within the profession, obviously, who have very strong views on this and i think that we — to deal with it, you know, we had to hold a line and say, you know, just because you're a professional society doesn't mean that you have the appropriate skill set to appraise the evidence. you know, at the bmj, we've been focusing on the evidence—based medicine movement for many, many decades, and particularly around too much medicine. so, whether that be for, i don't know, gestational diabetes or thyroid cancer. so, what we had to do is treat this as part of that, so that gender—based care for adolescents, was it an issue of too much medicine? and, jake kanter, if i could bring you in, from deadline, i wonder what your assessment of how the media reports on trans issues is. and i suppose, you know,